The Barclays Global FX Sales & Trading team is hosting its first-ever 'Commissions for Cancer' charitable event to benefit The Leukemia & Lymphoma Society (LLS).
From March 1–4, 2022, Barclays will donate 100% of net commissions earned globally from the BARX Gator algo platform to LLS, which means that client trading activity during this period will help further the important work of this cancer research organization.
Please contact the Barclays eFX sales team at BARXFXGlobal@barclays.com with any questions.
The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
The Leukemia & Lymphoma Society is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please consult with your tax advisor for more information.
Gator is a fee-based product which allows Barclays to combine liquidity available to Barclays through selected external venues with Barclays' principal liquidity. Gator is connected to a range of major FX external venues and offers access to multiple liquidity pools through a single execution channel.
More information about BARX and the Gator offering can be found on our BARX FX Brochures page here (login required).